Acute Coronary Syndrome

Meet the patient

A 58-year-old smoker arrives at 3am with central chest pressure he calls "an elephant on my chest", radiating to both arms, sweaty, nauseous, breathless for the last hour. The ECG shows ST elevation in V2 to V4. The cath lab is already being called before his troponin comes back.[1]

The two questions that decide his next hour are the two that decide every ACS: is the artery occluded? (the ECG answers within ten minutes) and can I open it in time? (the clock answers over the next two hours). Hold those two questions and everything below slots into place.[1]

One spectrum, one trigger, three faces

ACS is not three diseases — it is one plaque rupture read through two tests. Every episode begins the same way: an atherosclerotic cap tears or erodes, exposing thrombogenic core to flowing blood, and a platelet-and-fibrin clot forms over it. What happens next depends only on how completely that clot chokes the lumen — and the ECG plus troponin tell you that within an hour.[1]

The Fourth Universal Definition of Myocardial Infarction (2018) is the document examiners quote, and it draws one line every candidate must reproduce: acute myocardial injury is a rise and/or fall of troponin with at least one value above the 99th-percentile upper reference limit (URL). That injury only becomes infarction when there is also clinical evidence of ischaemia — symptoms, new ECG changes, Q waves, imaging evidence of lost myocardium, or a coronary thrombus. Troponin up in sepsis with a flat ECG is injury, not infarction; treat the sepsis.[3]

Because the mechanism matters as much as the label, the Universal Definition sorts MI into five types — and a final-prof candidate is expected to reproduce them:[3]

[3]

The classic trap: a septic, tachycardic patient with known coronary disease and a troponin bump is the ward's commonest Type 2 MI. Reaching for loading DAPT and rushing to angiography is the recurring trainee error — the artery did not rupture, the demand outran the supply, and the fix is the precipitant.[3]

The ECG-and-troponin fork — three faces

Two tests, applied early, do almost all of the diagnostic work. The bedside split every decision hangs on:[1]

[1]

The mechanistic split is the teaching point that earns marks: STEMI is a plumbing emergency — the artery must be opened now, regardless of how the biomarkers eventually look — while NSTE-ACS is a risk-stratification problem, where angiography is timed from the clinical picture, the ECG, and a validated score.[1]

One examiner favourite: why is unstable angina disappearing? Because high-sensitivity troponin now catches the small rises that used to be missed, reclassifying them as NSTEMI. Unstable angina survives only for the truly troponin-negative ischaemic presentation.[3]

Read the ECG like the cath lab does

The STEMI thresholds are the single most reproduced numbers in cardiology exams. New ST elevation at the J-point, in two contiguous leads:[1]

• At least 1 mm (0.1 mV) in every lead except V2–V3.
• In V2–V3: at least 2 mm in men aged 40 or older, 2.5 mm in men under 40, and 1.5 mm in women (any age).
• Contiguous means anatomically adjacent: II/III/aVF inferior, V1–V4 anterior or septal, I/aVL/V5–V6 lateral.
• New LBBB with a compatible history is a STEMI-equivalent.
• Posterior MI is a STEMI-equivalent: tall R waves with ST depression in V1–V2, confirmed by ST elevation in V7–V9.[1]

The classic trap: V1–V2 ST depression with tall R waves is not "ischaemia or NSTEMI" — it is a posterior STEMI-equivalent. Record V7–V9 and activate reperfusion; do not wait for the troponin. The ECG defines the emergency now; the troponin measures the infarct later.[1]

The earlier, subtler signs the cath lab looks for before the ST elevation is obvious:[1]

• Hyperacute T waves — tall, broad-based T waves within minutes of occlusion; the earliest electrical sign, and easily missed.
• de Winter T waves — upsloping ST depression in the anterior leads with tall symmetrical T waves and no STE; an LAD-occlusion equivalent.
• Wellens syndrome — deeply inverted or biphasic T waves in V2–V3 in a pain-free patient with critical proximal LAD stenosis; a pending-anterior-MI warning.
• Right ventricular infarction — ST elevation in V3R–V4R in the setting of inferior STEMI. Record right-sided leads in every inferior STEMI.
• Sgarbossa criteria in LBBB or a paced rhythm — concordant ST elevation at least 1 mm in any lead, concordant ST depression at least 1 mm in V1–V3, or discordant ST elevation at least 5 mm (Smith-modified uses a proportional ratio). Any one is highly specific.[1]

A normal first ECG does not exclude ACS. Serial ECGs every 15–30 minutes and troponin are needed, above all for circumflex-territory ischaemia, which is notoriously ECG-silent because the LCx supplies the high posterior wall the standard 12 leads barely see.[1]

How common, who, and why the plaque ruptures

Ischaemic heart disease is the leading cause of death worldwide, and in India it has overtaken infection as the number-one killer — a transition the NEET-PG and INICET examiner expects you to know. Risk factors split cleanly into the ones you cannot change and the ones you can.[1]

The non-modifiable set: age (risk rises steeply after 55 in men, 65 in women), male sex until menopause narrows the gap, family history of premature coronary disease (a first-degree relative under 55 in men, under 65 in women), and the genetic dyslipidaemias such as familial hypercholesterolaemia.[1]

The modifiable set, in order of how much they contribute: smoking (the single largest population-attributable risk, and the one whose cessation most rapidly lowers it), hypertension, diabetes (which roughly doubles cardiovascular risk and is treated as a coronary-risk equivalent), dyslipidaemia (raised LDL-C, low HDL-C), obesity, sedentary lifestyle, chronic kidney disease, and psychosocial stress.[1]

Not all risk factors accelerate atherosclerosis equally — some specifically thin the fibrous cap and prime it to rupture: smoking, hypertension, and hypercholesterolaemia. And when the patient does not fit the typical profile, name the non-atherosclerotic mimics: cocaine-induced spasm, spontaneous coronary artery dissection (SCAD) in peripartum women, coronary embolism from endocarditis or atrial fibrillation, coronary arteritis (Kawasaki, Takayasu), and paradoxical embolism through a patent foramen ovale.[1]

Time is muscle — the 20-minute wavefront

Atherosclerosis builds silently for decades — a fatty streak of lipid-laden macrophages (foam cells) appears even in adolescence, then matures into a fibrous plaque with a lipid-rich necrotic core under a cap of smooth muscle and collagen. ACS begins the moment that cap ruptures (the commonest mechanism, in inflamed thin-capped plaques) or erodes (more often in women, in plaques without a large lipid core), exposing core and tissue factor to flowing blood.[1]

The thrombus then builds along two parallel pathways — and each is the target of one limb of your immediate drug bundle:[1]

• Platelets adhere to exposed von Willebrand factor and collagen through GP-Ib and GP-VI, activate, release ADP and thromboxane A2, and cross-link through GP-IIb/IIIa binding fibrinogen. This is why aspirin (cyclo-oxygenase, thromboxane A2 blockade) and the P2Y12 inhibitors (ADP-receptor blockade) are the twin pillars.
• The coagulation cascade — tissue factor fires the extrinsic pathway, generating thrombin, which converts fibrinogen to fibrin and further activates platelets. This is the target of heparin, enoxaparin, and fondaparinux.[1]

How completely the thrombus chokes the lumen decides the syndrome. A totally occlusive clot cuts flow to the full wall thickness — transmural ischaemia, ST elevation, STEMI. A subtotal or mural clot leaves some flow, so the innermost subendocardium (the layer furthest from the epicardial supply, under the highest wall tension, last fed and first starved) ischaemia — ST depression or T inversion, NSTEMI if necrosis follows, unstable angina if it does not.[1]

The wavefront is the reason "time is muscle" is literal, not a slogan. Necrosis begins within roughly 20 minutes of complete occlusion and spreads from subendocardium to subepicardium the longer the artery stays shut: by 6 hours about 70 percent of the myocardium at risk is irreversibly dead. Coronaries are functional end-arteries with minimal acute collateral supply, which is why one vessel occluding can be catastrophic, and why every minute of reperfusion delay costs viable myocardium.[1]

The territory table is core exam material — memorise the mapping, because the ECG tells you the culprit before anyone opens the chest:[1]

[1]

Etymology for viva gold: infarction is from the Latin infarcire, "to stuff in" — the dead myocardium is, histologically, stuffed in among the living. Coronary comes from corona, "crown", because the arteries crown the heart. Both words outlived their metaphors because the pathology they describe is unchanged.[3]

Meet the atypical presentations — the ones that bite

Classic ACS pain is retrosternal pressure, tightness or heaviness, radiating to the left arm, both arms, neck, jaw, or epigastrium, lasting more than 20 minutes if infarction is evolving, with autonomic features — sweating, nausea, vomiting, dyspnoea, syncope. Effort pain becoming rest pain, crescendo angina, or new limiting angina all define the unstable patterns.[1]

It is the atypical presentations that hurt patients, because they are missed:[1]

• Women, the elderly, and diabetics may have dyspnoea alone, fatigue, epigastric pain, nausea, confusion, or syncope — and no crushing pain.
• Silent MI is discovered later on ECG (Q waves) or imaging; common in diabetes with autonomic neuropathy.
• Inferior MI hides as epigastric pain with vagal features (bradycardia, nausea) and is sent home as gastritis.
• Right ventricular infarction is inferior MI plus hypotension, clear lungs, and a raised JVP.
• Posterior MI may show almost nothing on a standard 12-lead.[1]

Three worked stems to carry into the viva:[1]

• A 70-year-old diabetic woman with sudden dyspnoea and no chest pain, anterior Q waves and a troponin rise — this is a silent anterior MI, not "CCF only". Work her up as ACS.
• A 45-year-old with tearing pain to the back and unequal arm blood pressures — this is dissection until proven otherwise, not MONA first. An anticoagulated dissection can be fatal.
• Post-prandial epigastric burning in a sweating smoker — ECG before antacid discharge.[1]

The killers that mimic ACS — exclude the dissection first

Several life-threatening mimics must be ruled out before you commit to ACS therapy, because antiplatelets and anticoagulants can be catastrophic if the true diagnosis is one of them. This table is the cornerstone of the chest-pain SAQ:[1]

[1]

The single differential to exclude clinically before treatment is aortic dissection: tearing, migrating pain to the back, a pulse or blood-pressure differential over 20 mmHg between limbs, a new aortic regurgitation murmur, a widened mediastinum on chest X-ray. Anticoagulating a dissection is potentially fatal, so the bundle waits until that possibility is addressed.[1]

Musculoskeletal pain, herpes zoster (where the pain can precede the rash), biliary colic (which mimics inferior MI through shared T7–T9 visceral afferents, and vice versa), and panic attacks round out the broader list — none of them is a diagnosis you may make before excluding the killers.[1]

The bedside round — look for complications, not the diagnosis

Examination in suspected ACS rarely provides a diagnostic sign; its job is to detect complications and assess haemodynamics. Run the focused cardiovascular examination in this order:[1]

• Pulse — rate and rhythm. Tachycardia points to hypovolaemia, pain, or arrhythmia; bradycardia points to conduction disease, especially in inferior MI from RCA occlusion of the AV-nodal artery.
• Blood pressure in BOTH arms — a differential over 20 mmHg raises dissection.
• JVP — raised in right-heart failure or right ventricular infarction.
• Heart sounds — an S3 signals ventricular dysfunction; a new murmur is a red flag for a mechanical complication (pansystolic suggests papillary muscle rupture or VSD).
• Lungs — crackles mean pulmonary oedema.
• Peripheries — cool, shut-down skin means cardiogenic shock.[1]

The Killip classification grades heart-failure severity at presentation and predicts in-hospital mortality directly — reproduce it verbatim:[1]

[1]

Higher Killip class escalates the urgency of monitoring and revascularisation and feeds the GRACE score. The bedside definition of cardiogenic shock — hypotension (systolic BP under 90 mmHg), signs of poor perfusion (cold clammy skin, oliguria, altered sensorium), and pulmonary oedema or low cardiac output — marks the patient who needs immediate, not deferred, revascularisation.[1]

Ten minutes, ninety minutes, two hours — the time-critical numbers

These are the numbers that win or lose an ACS stem, and they are non-negotiable.[1]

[1]

The 12-lead ECG, obtained and interpreted within 10 minutes of first medical contact, is the single most important initial test — it separates STEMI (reperfuse now, regardless of biomarkers) from everything else. High-sensitivity cardiac troponin is then run on a rapid algorithm: the ESC 0-hour/1-hour (or 0/3-hour) protocol triages patients into rule-out, observe, or rule-in bands based on absolute values and the magnitude of change — a rise/fall with at least one value above the 99th-percentile URL, in the right clinical context, defines infarction. The 0/1-hour pathway lets you safely discharge low-risk patients within an hour of arrival.[1]

Interpret troponin in context, always. Chronic stable elevations occur in renal failure; a small rise with a flat (non-rising) pattern means chronic injury, not acute infarction.[1]

Two named risk scores are essential for NSTE-ACS, reproduced exactly as the examiner expects:[1]

[1]

Adjunct investigations: chest X-ray (pulmonary oedema, a widened mediastinum raising dissection, pneumothorax); bedside echocardiography (regional wall-motion abnormality confirming ischaemia, ejection fraction, mechanical complications, effusion); bloods (FBC, U&E, glucose, fasting lipids); and coronary angiography, the definitive investigation and the gateway to PCI.[1]

MONA-B plus anticoagulant — the first-contact bundle

Every suspected ACS patient gets the same bundle at first contact, with two modern corrections that examiners now test: oxygen only if hypoxic, and morphine used sparingly because it blunts P2Y12 absorption.[1]

[1]

Two warnings recur in exams. First, routine high-flow oxygen in a normoxic patient is now contraindicated — DETO2X-AMI signalled harm from hyperoxia-driven coronary vasoconstriction, so oxygen is reserved for SpO2 under 90 percent or respiratory distress. Second, morphine slows gastric emptying and lowers the peak of oral ticagrelor and clopidogrel — treat the pain, but do not over-sedate.[4]

Aspirin deserves its own sentence. The ISIS-2 trial randomised over 17,000 patients with suspected acute MI to intravenous streptokinase, oral aspirin 162 mg for one month, both, or neither: aspirin alone cut 5-week vascular mortality by 23 percent — as much as streptokinase — and the combination halved mortality. The survival advantage was still there at 10-year follow-up.[2]

Ventricular fibrillation or pulseless VT in the first hours is the leading cause of pre-hospital death in acute MI, fully reversible with immediate defibrillation per advanced life support. The monitor pads and the bedside defibrillator exist for precisely this.[1]

The 120-minute fork — primary PCI or fibrinolysis

After the bundle, management forks on the ECG. STEMI goes to emergency reperfusion; NSTE-ACS goes to risk-stratified invasive timing.[1]

[1]

Primary PCI is preferred when it can be delivered within 120 minutes of first medical contact (door-to-balloon under 90 minutes). It achieves higher TIMI-3 flow than lysis, lowers reinfarction and stroke, and is the standard of care in PCI-capable centres. If PCI cannot meet the 120-minute window and the patient is within 12 hours of symptom onset (or has ongoing ischaemia), fibrinolyse within 30 minutes of arrival, then follow a pharmacoinvasive strategy — rescue PCI if lysis fails, routine early angiography within 3–24 hours if it succeeds. The fibrinolytic doses:[1]

[1]

Contraindications to fibrinolysis include prior intracranial haemorrhage, a known cerebral vascular lesion or malignancy, ischaemic stroke in the past 6 months, active bleeding, aortic dissection, and severe uncontrolled hypertension — these patients are transferred for PCI even if delayed.[1]

NSTE-ACS — a risk-stratification problem, not a plumbing emergency

NSTE-ACS is not a plumbing emergency. Angiography timing is chosen from risk features and a validated score, and the TIMACS trial is the evidence: an early invasive strategy (within 24 hours) reduced the composite of death, MI, or refractory ischaemia in high-risk patients without adding bleeding.[6]

[6]

DAPT and anticoagulation — name the drug, the dose, the trial

Dual antiplatelet therapy is the foundation: aspirin indefinitely plus a P2Y12 inhibitor, by default for 12 months after ACS, agent chosen by efficacy, bleeding risk, cost, and access. The landmark trials are core exam material:[1]

[5]

Ticagrelor (PLATO) and prasugrel (TRITON) are more potent than clopidogrel and preferred where affordable and not contraindicated; clopidogrel remains the workhorse in cost-constrained settings and where bleeding risk or an oral anticoagulant dominates.[5][4]

Parenteral anticoagulation options: unfractionated heparin (70–100 U/kg bolus for PCI), enoxaparin (1 mg/kg subcutaneously twice daily, halved in renal impairment), and fondaparinux (2.5 mg subcutaneously once daily — safest against bleeding, but not used as the sole anticoagulant during PCI, where UFH is added). Anticoagulation runs until PCI is completed, then typically stops (or continues through the index admission in a conservatively managed patient).[1]

The five pillars of secondary prevention

Every ACS survivor leaves hospital on the same disease-modifying bundle — as examinable as the acute ladder:[1]

[1]

This bundle, plus lifestyle (Mediterranean diet, regular exercise, weight management, alcohol moderation), is what drives the long-term reduction in recurrent events. Cardiac rehabilitation — structured exercise, education, and risk-factor modification — cuts mortality and rehospitalisation and should be offered to every eligible patient.[1]

Escalation — cardiogenic shock: inotropic and vasopressor support (noradrenaline may be preferred over dopamine; dobutamine for a low-output state) and urgent revascularisation. Mechanical circulatory support (intra-aortic balloon pump, percutaneous ventricular assist, ECMO) is considered in refractory cases — though IABP-SHOCK II showed no routine mortality benefit from balloon pumping in MI-related cardiogenic shock, so the IABP is now selective, not default.[7] Suspected mechanical complications (VSD, papillary muscle rupture, free-wall rupture) demand urgent echocardiography and cardiothoracic surgical referral.[1]

The subtypes that bite

Right ventricular infarction complicates inferior STEMI (proximal RCA occlusion cutting the RV marginal branches). The classic triad — hypotension, clear lung fields, and a raised JVP — is confirmed by ST elevation in V3R–V4R. Management is the opposite of left-sided failure: fluid loading to maintain RV preload (the RV is preload-dependent), with nitrates and diuretics avoided because they drop preload-dependent RV output. A nitrate-induced drop in BP during treatment of an inferior STEMI should immediately raise this possibility.[1]

Posterior wall MI is missed because the standard 12 leads do not directly visualise the posterior wall — it shows as tall R waves and ST depression in V1–V2 (a mirror of posterior ST elevation). Confirm with posterior leads V7–V9, then treat as a STEMI-equivalent and activate reperfusion.[1]

MI in the setting of LBBB — the broad, discordant QRS obscures the usual ST criteria. The Sgarbossa criteria (and the more sensitive Smith-modified version using a proportional ST/S ratio) identify ischaemic ST changes discordant with the QRS. A new LBBB with ischaemic symptoms is a STEMI-equivalent regardless.[1]

Spontaneous coronary artery dissection (SCAD) — a tear in the arterial wall creating a false lumen that compresses the true lumen. It predominantly affects young women without traditional risk factors, often peripartum or with fibromuscular dysplasia. Managed differently from Type 1 ACS: conservative therapy is preferred where the artery is patent (the dissection often heals spontaneously); stenting a dissection plane can extend it.[1]

Coronary vasospasm (Prinzmetal or variant angina) — transient, reversible ST elevation at rest, classically in the early morning, relieved by nitrates and calcium-channel blockers. The plaque may be non-critical; the mechanism is spasm. Manage with calcium-channel blockers and nitrates, avoiding beta-blockers (unopposed alpha vasoconstriction).[1]

An initially normal ECG with suspected ACS — repeat every 15–30 minutes, record right-sided (V3R–V4R) and posterior (V7–V9) leads in inferior or borderline cases, and chase serial troponin. Circumflex occlusion is the classic ECG-silent STEMI; if suspicion is high and the ECG normal, bedside echocardiography showing a regional wall-motion abnormality may reveal the territory.[1]

When the MI kills you later — complications by clock

Complications separate by timing, and the timing is the most examinable single fact about each. The clock matters more than the murmur.[1]

[1]

The three mechanical complications typically strike days 3–5, when necrosis has softened the myocardium to mush, and each carries a characteristic murmur — so a new pansystolic murmur days after MI is a red flag demanding urgent echocardiography and surgical referral. Papillary muscle rupture (usually the posteromedial muscle, supplied by the RCA alone, versus the anterolateral's dual LAD/LCx supply) produces acute severe mitral regurgitation with sudden pulmonary oedema. Ventricular septal rupture produces a harsh pansystolic murmur with a thrill at the lower left sternal border and biventricular failure. Free-wall rupture produces sudden cardiac tamponade with electromechanical dissociation, often fatal.[1]

Dressler syndrome — an autoimmune post-MI pericarditis presenting 2–10 weeks after the index event with fever, pleuritic chest pain, a pericardial rub, and a pericardial effusion, with raised inflammatory markers. Managed with NSAIDs and colchicine; steroids are reserved for refractory cases. It is distinct from the acute pericarditis of the first few days, which reflects direct transmural inflammation.[1]

The recurring pitfalls every candidate must name:[1]

• Failing to exclude aortic dissection before anticoagulating.
• Attributing epigastric pain to dyspepsia in a diabetic who is actually infarcting.
• Withholding reperfusion because the ECG is "borderline" — repeat it, record posterior and right-sided leads, look for STEMI-equivalents.
• Relying on a single negative troponin too early in the rise/fall curve — the 0/1-hour or 0/3-hour algorithm exists to avoid exactly this.
• Missing right ventricular infarction, giving nitrates, and precipitating profound hypotension.
• Treating a Type 2 MI with loading DAPT and a dash to angiography instead of treating the precipitant.[1]

How ACS patients come to harm — the preventable list

• Death from an unrecognised aortic dissection that was anticoagulated as "atypical MI" — the preventable death.[1]
• Inferior STEMI given nitrates that was a right ventricular infarct, ending in profound hypotension.[1]
• A posterior STEMI read as "NSTEMI with ST depression", delaying reperfusion.[1]
• A Type 2 MI in sepsis loaded with DAPT and sent for angiography, with a bleeding complication and no ischaemic benefit.[3]
• A mechanical complication on day 4 misread as "just heart failure" when a new murmur was the clue.[1]
• Aspirin omitted for a "possible gastritis" chest pain, or for a soft, non-absolute contraindication.[2]
• A large anterior infarct left without an echocardiogram, missing an LV thrombus.[1]
• DAPT stopped at three months because the patient felt well, with stent thrombosis the result.[1]

Prognosis, disposition, and the score that sets both

Mortality after ACS is set by infarct size, time to reperfusion, baseline risk (age, comorbidity, diabetes, CKD), Killip class at presentation, the GRACE score, and any mechanical or arrhythmic complication. With modern primary PCI, STEMI in-hospital mortality is roughly 5–6 percent; without reperfusion it was historically 15–20 percent. NSTE-ACS in-hospital mortality is often similar or slightly higher because that population is older and more comorbid with multivessel disease.[1]

Killip class at the bedside still predicts in-hospital mortality and drives disposition — CCU or ICU for class III or IV:[1]

[1]

GRACE estimates in-hospital and 6-month mortality from age, heart rate, systolic BP, creatinine, Killip class, cardiac arrest at admission, ST deviation, and elevated biomarkers. The thresholds that govern invasive timing in NSTE-ACS:[1]

• GRACE over 140 — high risk — early invasive within 24 hours.
• GRACE 109–140 — intermediate — invasive strategy generally within 72 hours.
• GRACE under 109 — lower risk — a selective, ischaemia-driven approach may be reasonable.[1]

TIMI (0–7) is simpler at the bedside: age at least 65, at least 3 CAD risk factors, known CAD stenosis at least 50 percent, aspirin in the past 7 days, at least 2 anginal episodes in 24 hours, ST deviation at least 0.5 mm, positive biomarker — each one point. Higher scores predict 14-day death, MI, or urgent revascularisation.[1]

Worked disposition stems:[1]

• Killip IV anterior STEMI — a 62-year-old, anterior STEMI, BP 78/50, cool extremities, pulmonary oedema: activate the cath lab now, CCU or ICU after PCI, consider mechanical circulatory support if shock is refractory, do not reach routinely for the IABP. Mortality without revascularisation is catastrophic.
• Low-risk NSTEMI — a 48-year-old with a troponin rise, normal ECG after pain resolution, GRACE 80, no ongoing pain: monitored ward, DAPT plus anticoagulant, early cardiology review; invasive strategy often during the index admission but not emergent if truly low risk and stable.
• Post-lysis rural transfer — after successful fibrinolysis (ST resolution over 50 percent, pain free), transfer for routine early angiography within 3–24 hours; if lysis failed (persistent ST elevation or pain at 60–90 minutes), rescue PCI.[1]

Recurrent event risk stays elevated indefinitely. Post-MI LV impairment, incomplete revascularisation, ongoing smoking, and DAPT non-adherence drive early stent thrombosis and late events. LV thrombus after a large anterior MI needs anticoagulation (typically 3 months) with the antiplatelet strategy individualised — echo surveillance is mandatory after large anterior infarcts.[1]

Special populations — presentation, reperfusion, and bleeding risk all change

Examiners use these scenarios heavily on NEET-PG and INICET.[1]

Diabetes mellitus. Atypical and silent MI is common (autonomic neuropathy blunts pain) — dyspnoea, nausea, fatigue, or just "unwell". Outcomes are worse (larger infarcts, more HF, more restenosis), so prefer an early invasive strategy in high-risk NSTE-ACS. Ticagrelor is preferred over clopidogrel when affordable (PLATO diabetic subgroup). In-hospital glycaemic control avoids both marked hyper- and hypoglycaemia — target roughly 7.8–10 mmol/L (140–180 mg/dL) in critically ill ACS, and do not chase tight control with unmonitored insulin infusions.[1]

Elderly and frail. They present with dyspnoea, syncope, delirium, a fall, or epigastric pain more than classic crushing pain. Bleeding risk on DAPT and anticoagulation is higher, so use PRECISE-DAPT and ARC-HBR concepts to individualise DAPT duration (often 1–3 months of dual therapy then de-escalation). Prasugrel is contraindicated at 75 years or older (TRITON-TIMI 38 excess ICH and bleeding) and if weight is under 60 kg or there is prior stroke or TIA. Prefer radial access, creatinine-adjusted anticoagulants, and shorter triple therapy if on an oral anticoagulant.[1]

Women and pregnancy-associated MI. Women present later, more atypically, and receive delayed reperfusion more often — a systems failure examiners flag. SCAD is a leading cause of MI in pregnancy and the peripartum period and in young women without traditional risk factors, often managed conservatively if stable. In pregnancy, protect the fetus (left lateral tilt, abdominal shielding, prefer echocardiography), because fibrinolysis is relatively contraindicated (placental abruption) and PCI is preferred when available. MINOCA (MI with non-obstructive coronaries) is more often diagnosed in women and needs cardiac MRI — consider spasm, plaque erosion, myocarditis, Takotsubo.[1]

Chronic kidney disease. Baseline troponin is often chronically elevated, so diagnose MI by a rise and/or fall pattern, not a single absolute value. Contrast-induced nephropathy risk at angiography: pre-hydrate with isotonic crystalloid when volume allows, minimise contrast, and delay non-urgent angiography if eGFR is critically low without ongoing ischaemia. Enoxaparin needs dose adjustment or avoidance at low CrCl; fondaparinux is contraindicated if CrCl is under 20 mL/min; UFH is often preferred at very low eGFR because it is fully reversible and titratable.[1]

Patients on oral anticoagulation (for example AF). After PCI for ACS, the default modern strategy is short triple therapy (OAC plus aspirin plus clopidogrel) for up to 1 week to 1 month, then dual therapy (OAC plus clopidogrel) to 6–12 months, then OAC monotherapy. Prefer clopidogrel as the P2Y12 with an OAC (less bleeding than ticagrelor or prasugrel), prefer a DOAC over warfarin when eligible, and always reassess HAS-BLED-style modifiers and add gastroprotection with a PPI.[1]

Cocaine and stimulant-associated ACS. The mechanism is vasospasm with or without plaque rupture plus a hyperadrenergic state. Give benzodiazepines early for agitation and hypertension; nitrates and calcium-channel blockers for spasm. Avoid pure beta-blockers early (theoretical unopposed alpha vasoconstriction) — if beta-blockade is needed after vasodilation, labetalol is sometimes used carefully. Still consider angiography if STEMI criteria are met — not all cocaine chest pain is spasm alone.[1]

Cardiogenic shock and post-arrest. Emergency revascularisation remains the cornerstone (SHOCK trial logic). Routine IABP is not indicated (IABP-SHOCK II) — reserve mechanical circulatory support for selected centres and phenotypes. Targeted temperature management after ROSC per local protocol; early angiography after out-of-hospital cardiac arrest with ST elevation is standard, and individualised without it.[7]

The trials that changed practice

The 2023 ESC Guidelines unified the previously separate STEMI and NSTE-ACS documents into a single "one syndrome" guideline, reflecting shared pathophysiology and overlapping early management. Headline recommendations: the 0/1-hour high-sensitivity troponin algorithm, default ticagrelor over clopidogrel, radial-artery access for PCI, complete revascularisation at the index event in STEMI multivessel disease, and de-escalation of antithrombotic therapy in lower-risk patients.[1]

The landmark trials an examiner expects you to cite, and what each changed:[1]

[2] [4] [5] [6] [7]

Regional deltas — the diagnostic and management framework (ECG, troponin, DAPT, timely reperfusion) is globally consistent, but resource-dependent choices differ:[1]

[1]

Controversies to name calmly: the routine-oxygen question (answered — no benefit, possible harm in normoxic patients); the morphine–P2Y12 interaction (a measurable pharmacokinetic effect, uncertain clinical impact); complete revascularisation versus culprit-only PCI in STEMI (COMPLETE favoured complete); and the optimal DAPT duration and de-escalation strategy (guided by bleeding versus ischaemic risk).[1]

The mantra, and the mnemonic

[1]

And never forget the P2Y12 inhibitor and the parenteral anticoagulant — they complete the immediate loading the mnemonic's five letters leave out.[1]

The mantra: ECG in ten minutes, aspirin three hundred milligrams, open the artery — everything else is refinements.[1][2]

Ward-round test — three stems, thirty seconds each

Stem 1 — the man from the top of the topic (answer)

The 58-year-old smoker with anterior ST elevation at 3am. The PCI centre is 3 hours away. What do you do in the next 30 minutes? Model: This is STEMI — primary PCI cannot meet the 120-minute window, so fibrinolyse within 30 minutes of arrival with tenecteplase as a single weight-based bolus (max 50 mg), after the immediate bundle (aspirin 300 mg chewed, a P2Y12 inhibitor, a parenteral anticoagulant) and after excluding contraindications to lysis and the clinical possibility of dissection. Then pursue a pharmacoinvasive strategy — transfer for routine early angiography within 3–24 hours if lysis succeeds, or rescue PCI if it fails (persistent ST elevation or pain at 60–90 minutes).[1]

Stem 2 — the inferior STEMI that drops its BP (answer)

An inferior STEMI becomes hypotensive the moment you give sublingual GTN. Lung fields are clear, JVP is raised. What happened, and what do you do? Model: This is right ventricular infarction — the nitrate dropped RV preload, and the RV is preload-dependent. Record right-sided leads V3R–V4R for ST elevation to confirm. No nitrates, no diuretics — give fluid boluses to restore RV preload. This is the classic "what not to do" trap, and it is why you record V3R–V4R in every inferior STEMI before reaching for the GTN.[1]

Stem 3 — the septic patient with a troponin bump (answer)

A 72-year-old on the ward with sepsis, heart rate 120, known coronary disease, has a troponin of 200 ng/L and a normal ECG. The registrar wants to load DAPT and call the cath lab. What is the right call? Model: This is Type 2 MI (supply-demand mismatch from tachycardia and hypotension on fixed CAD), or acute myocardial injury without ischaemic evidence — neither is the plaque-rupture pathway. Treat the precipitant: source control, fluids, oxygen, and rate control. Loading DAPT and rushing to angiography is the recurring trainee error that exposes the patient to bleeding without addressing the cause. Reserve the Type 1 pathway for ischaemic symptoms, new ECG changes, or a clear rise/fall troponin pattern in the right context.[3]

References

1. [1]Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes Eur Heart J, 2023.PMID 37622654
2. [2]Baigent C, Collins R, Appleby P, et al. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group BMJ, 1998.PMID 9563981
3. [3]Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018) J Am Coll Cardiol, 2018.PMID 30153967
4. [4]Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med, 2001.PMID 11519503
5. [5]Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med, 2009.PMID 19717846
6. [6]Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes N Engl J Med, 2009.PMID 19458363
7. [7]Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial Lancet, 2013.PMID 24011548